AKTX Forecast. What You Should Know.
AKTX Historical Ratings and Targets
About Akari Therapeutics Plc
Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-Barré syndrome, hematopoietic stem cell transplant-associated thrombotic microangiopathy, and bullous ... AKTX Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.